GB0706170D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0706170D0
GB0706170D0 GBGB0706170.8A GB0706170A GB0706170D0 GB 0706170 D0 GB0706170 D0 GB 0706170D0 GB 0706170 A GB0706170 A GB 0706170A GB 0706170 D0 GB0706170 D0 GB 0706170D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0706170.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0706170.8A priority Critical patent/GB0706170D0/en
Publication of GB0706170D0 publication Critical patent/GB0706170D0/en
Priority to PCT/EP2008/053593 priority patent/WO2008119714A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0706170.8A 2007-03-29 2007-03-29 Compounds Ceased GB0706170D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0706170.8A GB0706170D0 (en) 2007-03-29 2007-03-29 Compounds
PCT/EP2008/053593 WO2008119714A1 (en) 2007-03-29 2008-03-27 Compounds which have activity at m1 receptor and their uses in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0706170.8A GB0706170D0 (en) 2007-03-29 2007-03-29 Compounds

Publications (1)

Publication Number Publication Date
GB0706170D0 true GB0706170D0 (en) 2007-05-09

Family

ID=38050491

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0706170.8A Ceased GB0706170D0 (en) 2007-03-29 2007-03-29 Compounds

Country Status (2)

Country Link
GB (1) GB0706170D0 (en)
WO (1) WO2008119714A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5209479B2 (en) 2005-09-30 2013-06-12 グラクソ グループ リミテッド Benzimidazolones having activity at the M1 receptor
ES2391107T3 (en) 2005-09-30 2012-11-21 Glaxo Group Limited Compounds that have activity in the M1 receptor and their uses in medicine
US8283364B2 (en) 2005-09-30 2012-10-09 Glaxo Group Limited Compounds which have activity at M1 receptor and their uses in medicine
GB0718415D0 (en) 2007-09-20 2007-10-31 Glaxo Group Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5209479B2 (en) * 2005-09-30 2013-06-12 グラクソ グループ リミテッド Benzimidazolones having activity at the M1 receptor
ES2391107T3 (en) * 2005-09-30 2012-11-21 Glaxo Group Limited Compounds that have activity in the M1 receptor and their uses in medicine
US8283364B2 (en) * 2005-09-30 2012-10-09 Glaxo Group Limited Compounds which have activity at M1 receptor and their uses in medicine
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2008119714A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
GB0706793D0 (en) Compounds
GB0704407D0 (en) Compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0707092D0 (en) Compounds
GB0706188D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0707034D0 (en) Compounds
GB0706187D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706189D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0706190D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0701968D0 (en) Compounds
GB0705800D0 (en) Compounds
GB0701986D0 (en) Compounds
GB0706023D0 (en) Compounds
GB0702961D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)